These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21876564)

  • 1. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
    Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
    Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study.
    Simrén M; Bajor A; Gillberg PG; Rudling M; Abrahamsson H
    Aliment Pharmacol Ther; 2011 Jul; 34(1):41-50. PubMed ID: 21545606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.
    Chey WD; Camilleri M; Chang L; Rikner L; Graffner H
    Am J Gastroenterol; 2011 Oct; 106(10):1803-12. PubMed ID: 21606974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elobixibat for the treatment of constipation.
    Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2013 Feb; 22(2):277-84. PubMed ID: 23215781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial.
    Oduyebo I; Camilleri M; Nelson AD; Khemani D; Nord SL; Busciglio I; Burton D; Rhoten D; Ryks M; Carlson P; Donato L; Lueke A; Kim K; Rossi SJ; Zinsmeister AR
    Am J Gastroenterol; 2018 May; 113(5):725-734. PubMed ID: 29717197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
    Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophin-3 improves functional constipation.
    Parkman HP; Rao SS; Reynolds JC; Schiller LR; Wald A; Miner PB; Lembo AJ; Gordon JM; Drossman DA; Waltzman L; Stambler N; Cedarbaum JM;
    Am J Gastroenterol; 2003 Jun; 98(6):1338-47. PubMed ID: 12818279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans.
    Manabe N; Camilleri M; Rao A; Wong BS; Burton D; Busciglio I; Zinsmeister AR; Haruma K
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G970-5. PubMed ID: 20378829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
    Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR
    Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial.
    Kumagai Y; Amano H; Sasaki Y; Nakagawa C; Maeda M; Oikawa I; Furuie H
    Br J Clin Pharmacol; 2018 Oct; 84(10):2393-2404. PubMed ID: 29959787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
    Tiessen RG; Kennedy CA; Keller BT; Levin N; Acevedo L; Gedulin B; van Vliet AA; Dorenbaum A; Palmer M
    BMC Gastroenterol; 2018 Jan; 18(1):3. PubMed ID: 29304731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
    Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
    Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
    Verne GN; Davis RH; Robinson ME; Gordon JM; Eaker EY; Sninksy CA
    Am J Gastroenterol; 2003 May; 98(5):1112-6. PubMed ID: 12809836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
    Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
    Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.
    Mosińska P; Fichna J; Storr M
    World J Gastroenterol; 2015 Jun; 21(24):7436-42. PubMed ID: 26139989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.